Functional-proteomics-based investigation of the cellular response to farnesyltransferase inhibition in lung cancer
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Radiumhemmets Forskningsfonder (184133)
- Radiumhemmets Forskningsfonder (214133)
- Vetenskapsrådet (2022-03517)
- Karolinska Institutet (2019-00905)
- Cancerfonden
This publication has 87 references indexed in Scilit:
- Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applicationsCell, 2022
- Farnesyltransferase inhibition in HGPSCell, 2021
- Oncogenic Signaling Pathways in The Cancer Genome AtlasCell, 2018
- Parsing the Interferon Transcriptional Network and Its Disease AssociationsCell, 2016
- Employing ProteoWizard to Convert Raw Mass Spectrometry DataCurrent Protocols in Bioinformatics, 2014
- Regulation of Ferroptotic Cancer Cell Death by GPX4Cell, 2014
- Hepatic RIG-I Predicts Survival and Interferon-α Therapeutic Response in Hepatocellular CarcinomaCancer Cell, 2014
- Ras homologue enriched in brain is a critical target of farnesyltransferase inhibitors in non-small cell lung cancer cellsCancer Letters, 2010
- Synthesis and screening of a CaaL peptide library versus FTase reveals a surprising number of substratesBioorganic & Medicinal Chemistry Letters, 2010
- All ras proteins are polyisoprenylated but only some are palmitoylatedCell, 1989